Status: current, Defined. Date: 30-Jun 2009. Module: Australian Medicines Terminology module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 2695761000168112 | salicylic acid 4% + butyl hydroxybenzoate 1% + sodium propionate 0.2% powder | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
| 2695771000168118 | butyl hydroxybenzoate 10 mg / 1 g + salicylic acid 40 mg / 1 g + sodium propionate 2 mg / 1 g powder (medicinal product unit of use) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| salicylic acid 4% + butyl hydroxybenzoate 1% + sodium propionate 0.2% powder | has manufactured dose form | powder | true | Inferred relationship | Some | ||
| salicylic acid 4% + butyl hydroxybenzoate 1% + sodium propionate 0.2% powder | Is a | medicinal product unit of use | true | Inferred relationship | Some | ||
| salicylic acid 4% + butyl hydroxybenzoate 1% + sodium propionate 0.2% powder | Is a | salicylic acid + butyl hydroxybenzoate + propionic acid | true | Inferred relationship | Some | ||
| salicylic acid 4% + butyl hydroxybenzoate 1% + sodium propionate 0.2% powder | has intended active ingredient | salicylic acid | true | Inferred relationship | Some | 1445641320 | |
| salicylic acid 4% + butyl hydroxybenzoate 1% + sodium propionate 0.2% powder | has Australian BoSS | salicylic acid | true | Inferred relationship | Some | 1445641320 | |
| salicylic acid 4% + butyl hydroxybenzoate 1% + sodium propionate 0.2% powder | has intended active ingredient | propionic acid | true | Inferred relationship | Some | 1321082861 | |
| salicylic acid 4% + butyl hydroxybenzoate 1% + sodium propionate 0.2% powder | has Australian BoSS | sodium propionate | true | Inferred relationship | Some | 1321082861 | |
| salicylic acid 4% + butyl hydroxybenzoate 1% + sodium propionate 0.2% powder | has intended active ingredient | butyl hydroxybenzoate | true | Inferred relationship | Some | 741427048 | |
| salicylic acid 4% + butyl hydroxybenzoate 1% + sodium propionate 0.2% powder | has Australian BoSS | butyl hydroxybenzoate | true | Inferred relationship | Some | 741427048 | |
| salicylic acid 4% + butyl hydroxybenzoate 1% + sodium propionate 0.2% powder | has manufactured dose form | dusting powder | false | Inferred relationship | Some | ||
| salicylic acid 4% + butyl hydroxybenzoate 1% + sodium propionate 0.2% powder | has unit of use | continuous | true | Inferred relationship | Some | 1445641321 |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Mycoderm powder | Is a | True | salicylic acid 4% + butyl hydroxybenzoate 1% + sodium propionate 0.2% powder | Inferred relationship | Some | |
| salicylic acid 4% + butyl hydroxybenzoate 1% + sodium propionate 0.2% powder, 75 g | has MPUU | True | salicylic acid 4% + butyl hydroxybenzoate 1% + sodium propionate 0.2% powder | Inferred relationship | Some | 1 |
Reference Sets
Medicinal product unit of use reference set
FHIR